Inventor · disambiguated record
Wei Wang
Also filed as: WANG WEI · WANG WEI-BO
24 granted patents·5 pending applications·236 citations·filing 1995–2023
95Inventor score
Files withBRISTOL MYERS SQUIBB CO10ABBOTT LAB7UNIV ARIZONA3HEFEI INST PHYSICAL SCI CAS2BIOCHEM THERAPEUTICS INC1
Top patents by PatentIndex Score
29 records- 0192US7452907B2Conformationally constrained analogs useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 18, 2008·21 cites·16 claims
- 0292US5703244AProcess for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compoundsABBOTT LAB·Filed 1996·Granted Dec 30, 1997·53 cites·8 claims
- 0389US11168079B2Alkene compounds as farnesoid x receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 9, 2021·7 cites·11 claims
- 0488US5599816AQuinolizinone type compoundsABBOTT LAB·Filed 1995·Granted Feb 4, 1997·41 cites·31 claims
- 0587US7521557B2Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methodsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 21, 2009·11 cites·19 claims
- 0685US5945431ACytomegalovirus inhibiting compoundsBIOCHEM THERAPEUTICS INC·Filed 1997·Granted Aug 31, 1999·55 cites·28 claims
- 0779US7323570B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2006·Granted Jan 29, 2008·2 cites·5 claims
- 0879US7279485B2Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 9, 2007·11 cites·11 claims
- 0977US7105556B2Conformationally constrained analogs useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Sep 12, 2006·9 cites·17 claims
- 1076US7951793B2Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 31, 2011·2 cites·6 claims
- 1175US8415386B2Azolopyrrolone melanin concentrating hormone receptor-1 antagonistsDEVASTHALE PRATIK·Filed 2009·Granted Apr 9, 2013·3 cites·20 claims
- 1273US7211595B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2001·Granted May 1, 2007·5 cites·34 claims
- 1369US5726182AQuinolizinone type compoundsABBOTT LAB·Filed 1995·Granted Mar 10, 1998·12 cites·11 claims
- 1465US8658131B2Compounds comprising 4-benzoylpiperidine as a sigma-1-selective ligandTU ZHUDE·Filed 2011·Granted Feb 25, 2014·1 cites·17 claims
- 1562US11987564B2PTPRD inhibitors and uses thereofUS GOV VETERANS AFFAIRS·Filed 2022·Granted May 21, 2024·0 cites·16 claims
- 1660US2024173292A1Compounds that synergize with copper to kill streptococcus pneumoniaeUNIV ARIZONA·Filed 2023·Application pending·0 cites
- 1758US12291522B2Galectin-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted May 6, 2025·0 cites·16 claims
- 1854US12275719B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 15, 2025·0 cites·4 claims
- 1954US2024374580A1Small molecule inhibitors of autophagy and histone deactylases and uses thereofUNIV ARIZONA·Filed 2022·Application pending·0 cites
- 2048US2023022696A1Small molecule inhibitors of autophagy and histone deactylases and uses thereofUNIV ARIZONA·Filed 2020·Application pending·0 cites
- 2147US10793543B2Selective C-KIT kinase inhibitorPRECEDO PHARMACEUTICALS CO LTD·Filed 2017·Granted Oct 6, 2020·0 cites·8 claims
- 2245US5693813AProcess for preparation of 4H-4-oxo-quinolizine-3-carboxylic acidABBOTT LAB·Filed 1997·Granted Dec 2, 1997·3 cites·10 claims
- 2341US10851098B2Azole amides and amines as alpha v integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 1, 2020·0 cites·16 claims
- 2440US10669238B2Irreversible bruton's tyrosine kinase inhibitorHEFEI INST PHYSICAL SCI CAS·Filed 2016·Granted Jun 2, 2020·0 cites·21 claims
- 2539US2002115640A1Farnesyltransferase inhibitorsFiled 2001·Application pending·0 cites
- 2638US2002019527A1Substituted phenyl farnesyltransferase inhibitorsFiled 2001·Application pending·0 cites
- 2734US5837868AProcess for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compoundsABBOTT LAB·Filed 1997·Granted Nov 17, 1998·0 cites·9 claims
- 2833US10266535B2Inhibitor of FLT3 kinase and use thereofHEFEI INST PHYSICAL SCI CAS·Filed 2015·Granted Apr 23, 2019·0 cites·7 claims
- 2930US9974778B2Substituted pyridinones as MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 22, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Wei Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →